Email this article The role of triptorelin (Diphereline) in the treatment of prostate cancer
- Authors: Matveyev B.P.1
-
Affiliations:
- State Enterprise N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences
- Issue: Vol 4, No 4 (2008)
- Pages: 53-56
- Section: DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER
- Published: 30.12.2008
- URL: https://oncourology.abvpress.ru/oncur/article/view/1038
- DOI: https://doi.org/10.17650/1726-9776-2008-4-4-53-56
- ID: 1038
Cite item
Full Text
Abstract
Efficacy and safety issues of triptorelin (Diphereline) use in the treatment of patients with prostate cancer are addressed. Several clinical studies of efficacy of treatment with triptoreline both in mono-regimen and combined with other drugs are discussed.
About the authors
B. P. Matveyev
State Enterprise N.N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences
Author for correspondence.
Moscow Russian Federation
References
Supplementary files
